| 摘要 |
The present invention relates to methods and compositions for treating neuropathic pain and neuropsychiatric disorders by administering agents that are effective in reducing the effective amount, inactivating, and/or inhibiting the activity of a Na+—K+-2Cl−(NKCC) cotransporter. In certain embodiments, the Na+—K+-2Cl−co-transporter is NKCC1. |
